ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1256

Uptake of Influenza and Pneumococcal Vaccination in Inflammatory Arthritis

Kieran Murray1 and Douglas J. Veale2, 1Rheumatology, Rheumatology Specialist Registrar, Dublin 4, Ireland, 2Rheumatology, St. Vincent's University Hospital, Dublin 4, Ireland

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Influenza, Pneumococcal, Psoriatic arthritis, Rheumatoid Arthritis and Vaccination

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Inflammatory arthritides such as RA and PsA increase infection risk. The Centre for Disease Control and Prevention (CDC) recommends vaccination against i. influenza for all adults annually and ii. pneumococcus for all ‘at-risk’ adults (> 65 years, specific conditions or those taking certain immunosuppressants). The aim of this study was to examine patients’ knowledge, uptake and attitudes to influenza and pneumococcal vaccination, and to assess opportunities to increase vaccination rates in our inflammatory arthritis clinic.

Methods:

Patients attending the inflammatory arthritis clinic in St Vincent’s University Hospital, Dublin completed an anonymous 23 question worksheet while awaiting their physician. Demographic details, medical history, medications, knowledge about vaccinations, vaccination status, reasons for lack of vaccination and attitudes regarding willingness to use a smart phone for healthcare record were recorded.

Results:

125 patients responded, 79% were female and 71% were over 50 years of age. 83% had completed high school. Half of the patients had RA. 23% of patients were using methotrexate, 17% oral steroids and 34% an injectable biologic.

Awareness that rheumatological conditions increase risk of infection was reported by 51%, while 54% were aware that their medications can increase the infection risk. 67% were aware influenza vaccination was recommended, most commonly via their primary care physician (PCP) at 42%. 10% learnt of the need for vaccination through television or radio.

55% were up to date with their ‘flu’ vaccination, mainly (68%) via their PCP. 4% of patients received their last vaccine in hospital. Stated reasons for not being adequately vaccinated included lack of awareness (23%) and fear of side effects (15%).

66% were aware pneumococcal vaccination might be indicated, 42% were informed by their PCP. None were informed by television or radio. 47% of respondents were up to date with their pneumococcal vaccination, mainly (82%) via their PCP. 2% had been vaccinated in the hospital. 59% of those not adequately vaccinated cited lack of awareness as the reason.

75% of patients had access to a smart phone. 76% were willing to use their smart phone for their healthcare record and reminder re vaccinations.

Conclusion:

Patient awareness of the risk of infection associated with disease and treatment was low. Although over two thirds were aware of influenza and pneumococcal vaccination recommendations, significantly fewer patients were up-to-date with their vaccinations. The majority of vaccinations took place in the community. The use of mass media and mobile technology may be an effective means of increasing vaccination uptake.


Disclosure: K. Murray, None; D. J. Veale, None.

To cite this abstract in AMA style:

Murray K, Veale DJ. Uptake of Influenza and Pneumococcal Vaccination in Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/uptake-of-influenza-and-pneumococcal-vaccination-in-inflammatory-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/uptake-of-influenza-and-pneumococcal-vaccination-in-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology